Navigating the Intersection of Health Equity and Chronic Care
Esteemed leaders from CVS Health, Florida Blue, Highmark, and Vori Health delved into the impact of health equity on chronic care. They not only shared strategies and solutions to enhance healthcare accessibility but also shed light on specific programs they have successfully implemented to bridge the health equity gap in chronic disease prevention and treatment.
Guests:
-
Joneigh S. Khaldun, MD, MPH, FACEP, Vice President and Chief Health Equity Officer, CVS Health
-
Kelli Tice, MD, Vice President, Medical Affairs & Chief Health Equity Officer, Florida Blue
-
Nebeyou Abebe, Senior Vice President, Social Determinants of Health, Highmark Health
-
Mary O’Connor, MD, Co-Founder & Chief Medical Officer, Vori Health
Navigating the Intersection of Health Equity and Chronic Care
Links to programs mentioned during the episode
-
Advancing Health Equity | CVS Health: https://www.cvshealth.com/impact/health-equity.html
-
CVS Health launches Community Equity Alliance to improve health outcomes in underserved communities: https://www.cvshealth.com/news/health-equity/cvs-health-launches-community-equity-alliance-to-improve-health-outcomes.html
-
Spoken Rx – Prescription Reader | CVS Pharmacy: https://www.cvs.com/content/pharmacy/spoken-rx
-
Highmark Community Support Platform: https://highmark.findhelp.com/
This episode is sponsored by our partner, Vori Health
Vori Health is a specialty medical practice delivering a virtual-first musculoskeletal (MSK) solution to help members get back to their lives faster. As the only nationwide MSK practice with doctor-led care teams, Vori Health is the most convenient way to access appropriate care for back, neck, and joint pain without bouncing around the healthcare system. Whether members need a diagnosis, non-opioid prescription, personalized physical therapy, or health coaching, they can turn to Vori Health for evidence-based care and effective end-to-end support. This holistic model reduces unnecessary surgeries, enables faster recoveries, and lowers MSK spend with up to a 4:1 ROI. For more information, visit www.vorihealth.com.
